Intellectual Property

  • July 21, 2026

    Boehringer Alleges United Therapeutics Poached Staff, Secrets

    Boehringer Ingelheim Pharmaceuticals Inc. is suing United Therapeutics Corp. in Delaware Chancery Court, alleging it recruited more than 20 members of Boehringer's specialized interstitial lung disease sales team to obtain confidential business information before launching a competing drug.

  • July 21, 2026

    DirecTV Sues Over Va. Fraud Scheme

    DirecTV has filed suit against a Virginia man and a group of companies, alleging that they engaged in a scheme to defraud DirecTV customers.

  • July 21, 2026

    College Advising Co. Drops Contract Row With Ex-Franchisee

    A college consulting company has dropped its lawsuit accusing a former franchisee of filching its proprietary methods and starting a new venture, North Carolina federal court records show.

  • July 20, 2026

    Moderna Hits CureVac With Countersuit In COVID Vax Fight

    Moderna has filed a countersuit in Delaware federal court against a BioNTech subsidiary's claims that Moderna's COVID-19 vaccine infringed several patents, saying the rival biotech company was trying to "take credit" for Moderna's own innovations in mRNA vaccines.

  • July 20, 2026

    Google Data Sharing With Temu Violates DOJ Rule, Suit Says

    Google shares internet users' sensitive information with Chinese e-commerce giant Temu and a technology firm the Pentagon calls a "Chinese military company," violating a U.S. Department of Justice rule preventing the bulk transmission of data to "countries of concern," according to a proposed class action in California federal court.

  • July 20, 2026

    Cox, Insurers Battle For Early Win In Media Coverage Suit

    Cox Enterprises and two insurers competed Monday for an early win in the company's suit alleging it was wrongly denied coverage for more than $15 million in expenses spent defending, and ultimately settling, a lawsuit that aimed to hold the internet service provider liable for users' illegal downloads.

  • July 20, 2026

    Anthropic's $1.5B Copyright Deal With Authors Gets Final OK

    A California federal judge on Monday gave final approval to Anthropic's $1.5 billion settlement resolving authors' allegations the artificial intelligence company pirated their work to train its flagship product, Claude, setting aside roughly $101.5 million in attorney fees for class counsel.

  • July 20, 2026

    Apple Can't Get Judge To Toss Masimo's $634M Patent Verdict

    Apple has lost its bid to dodge a jury's finding that it owes $634 million for infringing a Masimo Corp. patent after a California federal judge rejected the tech giant's challenge to how the court construed a key term and its bid for a new trial.

  • July 20, 2026

    Joby Looks To Beat Aerosonic's Air Data Probe IP Suit

    Joby Aero Inc. is doubling down on its efforts to defeat Aerosonic LLC's case alleging Joby stole proprietary information over certain air data probes, arguing in a filing Friday that allegedly reverse engineering the technology is not a violation of trade secret law.

  • July 20, 2026

    JPMorgan Infringed Privacy Tech Patents, Software Co. Claims

    JPMorgan Chase's payment processing systems have been infringing a trio of patents covering technology meant to protect data during transactions, according to a lawsuit filed in Texas federal court.

  • July 20, 2026

    Del. Judge Rejects Fast-Track Bid For Agtech Co. Receiver

    The Delaware Chancery Court on Monday refused to fast-track a former HerdDogg Inc. founder's bid to place the agricultural technology company into receivership and denied her request for a temporary restraining order, finding she failed to show current evidence of insolvency or an imminent threat of irreparable harm.

  • July 20, 2026

    DOJ Says It Shut Down 1K Illegal World Cup Streaming Sites

    The U.S. Department of Justice seized more than 1,000 internet domains that were used for unauthorized streaming of the FIFA World Cup, the agency said Monday.

  • July 20, 2026

    4th Circ. Remands Models' Image-Misuse Coverage Fight

    An insurance company's coverage dispute with a Virginia Beach restaurant accused by a group of models of misappropriating their images was sent back to the district court Monday by the Fourth Circuit to determine if the lawsuit became moot when the restaurant settled with the models.

  • July 20, 2026

    Amazon Says Atty's Defense In TM Suit Still Baseless

    Amazon has asked a Washington federal judge to reject a renewed motion to dismiss from a California attorney being sued for alleged participation in a trademark fraud scheme, claiming she was rehashing arguments from her prior motion, which the company said was riddled with artificial intelligence-generated hallucinations.

  • July 20, 2026

    Lexi Love Can Pull Paramount Into 'Drag Race' TM Suit

    A California federal judge has denied a bid from Paramount and the studio behind RuPaul's Drag Race to escape trademark litigation between actress and former porn star Lexi Love and a drag queen who uses the same name, saying First Amendment protections don't apply to their usage of the moniker.

  • July 20, 2026

    Lathrop GPM To Expand In Calif., NY, UK With IP Firm Combo

    Lathrop GPM LLP announced Monday that it has agreed to combine with intellectual property firm HG Law at the start of January, which would expand its capabilities in the Silicon Valley market and give the firm a presence in New York and London.

  • July 20, 2026

    NC Pool Companies Settle Trademark Infringement Suit

    A pool and spa service provider serving the Outer Banks who accused a competitor of infringing on its trademarks has settled the lawsuit, according to a notice filed in North Carolina federal court.

  • July 20, 2026

    Fed. Circ. Told Decision Clearing Sirius In Patent Case Flawed

    German research institute Fraunhofer-Gesellschaft has urged the Federal Circuit to revive its patent suit against SiriusXM, saying a lower court made various errors when deciding that the satellite radio giant relied on a delay in bringing the suit.

  • July 20, 2026

    Samsung Directed To Pay Interest Atop $445M Patent Verdict

    A Texas federal judge has ordered Samsung to pay prejudgment and postjudgment interest on a $445 million jury verdict that found the South Korean electronics firm was infringing patents covering wireless communications network efficiency.

  • July 20, 2026

    Akerman, Hilgers IP Pros Join Kane Russell In Texas

    Texas regional firm Kane Russell Coleman Logan PC has bolstered its intellectual property offerings with new directors in Austin and Dallas, one joining from Akerman LLP and another from Hilgers PLLC.

  • July 20, 2026

    Emirates Stole Meal-Booking Trade Secrets, Startup Says

    An aviation technology startup accused aviation holding company The Emirates Group and two affiliates of stealing trade secrets for a passenger meal-preordering platform and launching a copycat service, according to a Colorado federal court complaint.

  • July 20, 2026

    4 Patent Cases To Watch In The Second Half Of 2026

    New limits on the ability to challenge patents tied to when they were issued, the invalidity standards for antibody patents and the test for design patent infringement are all at issue in cases patent attorneys will be monitoring for the rest of the year.

  • July 20, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court last week tackled disputes involving intellectual property, corporate control, fiduciary duties, artificial intelligence, trust administration and cryptocurrency litigation.

  • July 17, 2026

    Toy Seller Used 'Space Jam' In Ads Without License, Suit Says

    A Florida-based music publisher has filed a copyright suit against a wholesale toy supplier in Georgia federal court over the song "Space Jam," which served as the main theme song for the film of the same name, alleging the company used the tune to promote and market its business without obtaining a license to do so.

  • July 17, 2026

    US Seeks Toss Of Arbutus Patent Suit Over Moderna Vaccine

    The federal government asked the U.S. Court of Federal Claims on Friday to dismiss much of a patent suit against it by Arbutus Biopharma tied to Moderna's COVID-19 vaccine, saying the court couldn't hear the bulk of the case because Arbutus and Moderna reached a multibillion-dollar consent judgment that is subject to appeal.

Expert Analysis

  • Series

    Teaching Logic Makes Me A Better Lawyer

    Author Photo

    Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.

  • From IPR To EPR: The Rapid Rise Of Ex Parte Reexamination

    Author Photo

    With the current administration's dramatic shifts in policy rendering inter partes reviews essentially unavailable for the majority of patents being asserted in litigation, IPR filing rates have plunged, and ex parte reexamination requests have surged to the average rate of IPR petitions in 2024, say attorneys at McKool Smith.

  • Series

    Law School's Missed Lessons: Practicing Resilience

    Author Photo

    Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.

  • Upshot Of 'Skinny Label' Case May Go Beyond Pharma

    Author Photo

    The U.S. Supreme Court's pending review of Hikma v. Amarin, over a drugmaker's "skinny label," carries implications for both generics and brand-name pharmaceutical manufacturers, and could shed light on how inducement doctrine should operate in other regulated industries where products have substantial lawful uses, says Jason Shull at Banner Witcoff.

  • Assessing Factors Behind Biosimilar Uptake And Competition

    Author Photo

    As biosimilar uptake remains uneven and questions linger over whether the Biologics Price Competition and Innovation Act can deliver robust competition between biologics and biosimilars, a case study of Humira and its biosimilars illustrates how many factors, including payor reimbursement and formulary strategy, collectively shape competitive dynamics, say analysts at Analysis Group.

  • How 2 Tech Statutes Are Being Applied To Agentic AI

    Author Photo

    The application of the Computer Fraud and Abuse Act and the California Invasion of Privacy Act to agentic artificial intelligence is still developing, but recent case law, like Amazon's lawsuit against Perplexity in California federal court, provides some initial guidance for companies developing or deploying these technologies, say attorneys at Weil.

  • FTC Focus: Testing Joint Enforcement Over Loyalty Programs

    Author Photo

    The Federal Trade Commission's case against Syngenta can be understood both as a canary for further scrutiny over loyalty-discount practices and a signal of the durability of joint federal-state antitrust enforcement, with key takeaways for practitioners and those subject to regulatory antitrust scrutiny alike, say attorneys at Proskauer.

  • NYC Bar Opinion Warns Attys On Use Of AI Recording Tools

    Author Photo

    Attorneys who use artificial intelligence tools to record, transcribe and summarize conversations with clients should heed the New York City Bar Association’s recent opinion addressing the legal and ethical risks posed by such tools, and follow several best practices to avoid violating the Rules of Professional Conduct, say attorneys at Smith Gambrell.

  • Series

    The Biz Court Digest: Dispatches From Utah's Newest Court

    Author Photo

    While a robust body of law hasn't yet developed since the Utah Business and Chancery Court's founding in October 2024, the number of cases filed there has recently picked up, and its existence illustrates Utah's desire to be top of mind for businesses across the country, says Evan Strassberg at Michael Best.

  • Checking In On Biologics-Related Patent Review Trends

    Author Photo

    Comprehensive analysis of Patent Trial and Appeal Board data since the PTAB's creation indicates that while inter partes review and post-grant review are potent weapons for challenging biologics-related patents, recent policy changes may reduce their effectiveness, say attorneys at Steptoe.

  • 4 Quick Emotional Resets For Lawyers With Conflict Fatigue

    Author Photo

    Though the emotional wear and tear of legal work can trap attorneys in conflict fatigue — leaving them unable to shake off tense interactions or return to a calm baseline — simple therapeutic techniques for resetting the nervous system can help break the cycle, says Chantel Cohen at CWC Coaching & Therapy.

  • Patent Eligibility Faces Widening Gap Between USPTO, Courts

    Author Photo

    The year 2026 opened with a profoundly altered Patent Act Section 101 ecosystem — the U.S. Patent and Trademark Office has pushed eligibility as far open as it can for artificial intelligence technologies, but the courts are not on the same page, say attorneys at Skadden.

  • Series

    Playing Tennis Makes Me A Better Lawyer

    Author Photo

    An instinct to turn pain into purpose meant frequent trips to the tennis court, where learning to move ahead one point at a time was a lesson that also applied to the steep learning curve of patent prosecution law, says Daniel Henry at Marshall Gerstein.

  • Expect Major Shifts In Patent And Trademark Policy This Year

    Author Photo

    New leadership and initiatives promise to bring consequential changes to the U.S. Patent and Trademark Office's practices in 2026, likely favoring patent allowance and issuance, as well as streamlining trademark processes, say attorneys at Knobbe Martens.

  • And Now A Word From The Panel: MDL Year In Review

    Author Photo

    2025 was a roller coaster for the Judicial Panel on Multidistrict Litigation, with the panel canceling one hearing session due to the absence of new MDL petitions, yet also issuing rulings on more new MDL petitions than in 2024 — making it clear that MDLs are still thriving, says Alan Rothman at Sidley Austin.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.